This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nancy, P. Articles by Berrih-Aknin, S. Search for Related Content PubMed PubMed Citation Articles by Nancy, P. Articles by Berrih-Aknin, S.

Differential Estrogen Receptor Expression in Autoimmune Myasthenia Gravis

Centre National de la Recherche Scientifique-Unité Mixte de Recherche 8078, Institut Paris-Sud Cytokines, Université Paris XI, Hôpital Marie Lannelongue, 92350 Le Plessis-Robinson, France

Address all correspondence and requests for reprints to: Sonia Berrih-Aknin, Unité Mixte de Recherche Université Paris-Sud Centre National de la Recherche Scientifique-8078, Institut Paris-Sud Cytokines, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis-Robinson, France. E-mail: sonia.berrih{at}ccml.u-psud.fr.

Myasthenia gravis (MG) is an autoimmune disease associated with thymic hyperplasia and is much more prevalent in women than men. In this study we investigated potential changes in estrogen receptor (ER) expression in thymic hyperplasia. We first quantified by real-time PCR the relative expression of ER and ERß in normal thymus and found that the ERß to ER ratio was inverted in thymocytes (8.6 ± 1.2), compared with thymic epithelial cells (0.18 ± 0.05). The ER transcript number gradually decreased in thymic epithelial cells during culture, indicating that the thymic environment influences ER expression. CD4⁺ helper T cells expressed higher level of ERs, compared with CD8⁺ cells, as assessed by flow cytometry in thymocytes and peripheral blood mononuclear cells. In MG patients, we found an increased expression of ER on thymocytes and both ERs on T cells from peripheral blood mononuclear cells, indicating that the signals provided by thymic and peripheral microenvironments are distinct. Finally, activation of normal thymocytes by proinflammatory cytokines induced increased expression of ERs especially in the CD4⁺ subset, suggesting that an excess of proinflammatory cytokines could explain the increase of ERs expression on MG lymphocytes. The dysregulation of ER expression in MG lymphocytes could affect the maintenance of the homeostatic conditions and might influence the progression of the autoimmune response.

This article has been cited by other articles:

				A. Meraouna, G. Cizeron-Clairac, R. L. Panse, J. Bismuth, F. Truffault, C. Tallaksen, and S. Berrih-Aknin The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis Blood, July 15, 2006; 108(2): 432 - 440. [Abstract] [Full Text] [PDF]